Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lhermusier

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Thrombosis and Haemostasis : JTH|October 1, 2011
Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndromeT Lhermusier, H Chap, B Payrastre
Journal of Thrombosis and Haemostasis : JTH|July 4, 2012
Switching patients from clopidogrel to prasugrel in acute coronary syndrome: effects of prasugrel loading dose on residual platelet reactivityT Lhermusier, S Voisin, S Mejean, et al.
Platelets|October 7, 2011
Targeted drug therapy: the platelet sideT Lhermusier, J Van Rothem, C Garcia, et al.
Journal of Thrombosis and Haemostasis : JTH|January 5, 2011
More on: adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrelM A Tidjane, S Voisin, T Lhermusier, et al.
Annales De Cardiologie Et D'Angeiologie|November 9, 2010
[Left ventricular assist devices in cardiogenic shock]N Boudou, B Marcheix, C Biendel-Piquet, et al.
International Journal of Cardiology|May 14, 2014
Switching patients from clopidogrel to novel P2Y12 receptor inhibitors in acute coronary syndrome: comparative effects of prasugrel and ticagrelor on platelet reactivityT Lhermusier, S Voisin, G Murat, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 9, 2009
Long-term clinical outcome after percutaneous coronary interventions in the elderly: results for 512 consecutive patientsN Boudou, J Roncalli, T Lhermusier, et al.
Journal of Thrombosis and Haemostasis : JTH|August 19, 2011
The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodiesT Lhermusier, J van Rottem, C Garcia, et al.
European Radiology|November 23, 2006
Evaluation of in-stent restenosis in proximal coronary arteries with multidetector computed tomography (MDCT)V Chabbert, D Carrie, M Bennaceur, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2016
ATP-binding cassette transporter 1 (ABCA1) deficiency decreases platelet reactivity and reduces thromboxane A2 production independently of hematopoietic ABCA1T Lhermusier, S Severin, J Van Rothem, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Thrombosis and Haemostasis : JTH|October 1, 2011
Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndromeT Lhermusier, H Chap, B Payrastre
Journal of Thrombosis and Haemostasis : JTH|July 4, 2012
Switching patients from clopidogrel to prasugrel in acute coronary syndrome: effects of prasugrel loading dose on residual platelet reactivityT Lhermusier, S Voisin, S Mejean, et al.
Platelets|October 7, 2011
Targeted drug therapy: the platelet sideT Lhermusier, J Van Rothem, C Garcia, et al.
Journal of Thrombosis and Haemostasis : JTH|January 5, 2011
More on: adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrelM A Tidjane, S Voisin, T Lhermusier, et al.
Annales De Cardiologie Et D'Angeiologie|November 9, 2010
[Left ventricular assist devices in cardiogenic shock]N Boudou, B Marcheix, C Biendel-Piquet, et al.
International Journal of Cardiology|May 14, 2014
Switching patients from clopidogrel to novel P2Y12 receptor inhibitors in acute coronary syndrome: comparative effects of prasugrel and ticagrelor on platelet reactivityT Lhermusier, S Voisin, G Murat, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 9, 2009
Long-term clinical outcome after percutaneous coronary interventions in the elderly: results for 512 consecutive patientsN Boudou, J Roncalli, T Lhermusier, et al.
Journal of Thrombosis and Haemostasis : JTH|August 19, 2011
The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodiesT Lhermusier, J van Rottem, C Garcia, et al.
European Radiology|November 23, 2006
Evaluation of in-stent restenosis in proximal coronary arteries with multidetector computed tomography (MDCT)V Chabbert, D Carrie, M Bennaceur, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2016
ATP-binding cassette transporter 1 (ABCA1) deficiency decreases platelet reactivity and reduces thromboxane A2 production independently of hematopoietic ABCA1T Lhermusier, S Severin, J Van Rothem, et al.
Pageof 2